Gut microbiome development along the colorectal adenoma-carcinoma sequenceOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how the gut microbiome changes along the colorectal adenoma-carcinoma sequence, the stepwise progression from benign polyps to invasive cancer. Researchers used a metagenome-wide association study (MGWAS) on stool samples to catalogue microbial genes, strains, and functional pathways at each stage. The goal was to identify which gut microbes and functions are specifically enriched in adenoma versus carcinoma, since colorectal cancer often develops slowly from these precursor polyps and the microbiota is thought to play a direct role in that process.
Who was studied?
The comparison groups were stool samples from patients with advanced adenoma, patients with carcinoma, and healthy control subjects. The abstract does not report specific sample sizes, ages, or geographic origin of the cohort. Beyond identifying these three clinical groups, the analysis also incorporated dietary risk-factor data, specifically relative intake of red meat versus fruits and vegetables.
What were the most important findings?
The MGWAS revealed distinct sets of microbial genes, strains, and functions that were enriched in the adenoma group and in the carcinoma group compared with healthy subjects, indicating that the gut microbiome shifts in a stage-specific way along this disease sequence. A risk-factor analysis linked higher intake of red meat relative to fruits and vegetables with the outgrowth of bacteria that may help create a more hostile, pro-carcinogenic gut environment. The abstract does not name specific taxa such as Bilophila, Desulfovibrio, or sulfate-reducing bacteria, nor does it mention hydrogen sulfide, bile acids, or taurine.
What are the greatest implications of this study?
By mapping microbial changes across the adenoma-carcinoma sequence, the findings support the idea that stool-based microbiome signatures could serve as biomarkers for early, non-invasive detection of colorectal adenoma or carcinoma. The diet-microbiome link suggests that dietary patterns high in red meat relative to plant foods may promote a gut microbial environment conducive to disease progression, pointing to a modifiable risk factor. Together, these results suggest faecal microbiome profiling could inform both earlier diagnosis and future microbiome-targeted treatment strategies for colorectal cancer.